CC-115 hydrochloride is primarily used in the field of oncology and immunology due to its ability to inhibit specific enzymes involved in cell growth and immune response. It targets both DNA-PK and mTOR pathways, making it a dual inhibitor. This dual action is particularly useful in cancer therapy, as it can disrupt the repair mechanisms of cancer cells and suppress their growth. It is being investigated in clinical trials for the treatment of various cancers, including solid tumors and hematologic malignancies. Additionally, its immunosuppressive properties are being explored for potential use in autoimmune diseases, where it may help modulate overactive immune responses. Its application in precision medicine highlights its potential to improve therapeutic outcomes in complex diseases.